abstract
- After looking at data used to support treatment of women with slightly lowered bone mineral density, Pablo Alonso-Coello and colleagues argue thatproponents have overstated the benefits and underplayed the harms
Drugs for pre-osteoporosis: prevention or disease mongering?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- January 19, 2008
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Bone Density Conservation Agents (MeSH)
- Conflict of Interest (MeSH)
- Female (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Marketing of Health Services (MeSH)
- Meta-Analysis as Topic (MeSH)
- Osteoporosis (MeSH)
- Risk Assessment (MeSH)
- Risk Factors (MeSH)
published in
- The BMJ Journal